Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)

Molecular Endocrinology

Volumn 11, Issue 11, 1997, Pages 1593-1607

  Groshong, Steve D ^a   Owen, Gareth I ^a   Grimison, Bryn ^a   Schauer, Irene E ^a   Todd, Maria C ^a   Langan, Thomas A ^a   Sclafani, Robert A ^a   Lange, Carol A ^a   Horwitz, Kathryn B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROMEGESTONE; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030775651     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.11.0006     Document Type: Article

References (72)

1. Clarke CL, Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocr Rev 11:266-302
2. Horwitz KB 1992 The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 13:146-163
3. Horwitz KB, McGuire WL, Pearson OH, Segaloff A 1975 Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189:726-727
4. Clark GM, McGuire WL, Hubay CA 1983 Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 309:1343-1347
5. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
6. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630
7. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL 1993 Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577-3587
8. Musgrove EA, Lee CS, Buckley MF, Sutherland RL 1994 Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91:8022-8026
9. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV 1994 Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671
10. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593
11. Cummings SR 1991 Evaluating the benefits and risks of postmenopausal hormone therapy. Am J Med 91: 14S-18S
12. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA 1995 Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 274:137-142
13. Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ 1989 Oral contraceptive use influences resting breast proliferation. Hum Pathol 20:1139-1144
14. Going JJ, Anderson TJ, Battersby S, Macintyre CCA 1988 Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130:193-204
15. Potten CS, Watson RJ, Williams GT 1988 The effect of age and menstrual cycle upon proliferative activity of normal human breast. Br J Cancer 58:163-170
16. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GH, Beach D, Lassar AB 1995 Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
17. Pardee AB 1989 G1 events and regulation of cell proliferation. Science 246:603-608
18. Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027
19. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME 1994 Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396
20. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D 1993 p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
21. Skapek SX, Rhee J, Spicer DB, Lassar AB 1995 Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024
22. Horwitz KB, McGuire WL 1978 Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253:2223-2228
23. Dickson RB, Lippman ME 1995 Growth factors in breast cancer. Endocr Rev 16:559-589
24. Musgrove EA, Lee CSL, Sutherland RL 1991 Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor a, epidermal growth factor receptor, c-fos, and c-myc genes. Mol Cell Biol 11:5032-5043
25. Horwitz KB, Alexander PS 1983 In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113:2195-2201
26. Meyer M-E, Quirin-Stricker C, Lerouge T, Bocquel M-T, Gronemeyer H 1992 A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J Biol Chem 267:10882-10887
27. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB 1994 A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8:1347-1360
28. Tora L, Gronemeyer H, Turcotte B, Gaub M-T, Chambon P 1988 The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333:185-187
29. Boyd-Leinen PA, Fournier D, Thomas CS 1982 Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. Endocrinology 111:30-36
30. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL 1995 Characterisation of progesterone receptor A and B expression in human breast cancer. Cancer Res 55:5063-5068
31. Kato J, Hirata S, Nozawa A, Mouri N 1993 The ontogeny of gene expression of progestin receptors in the female rat brain. J Steroid Biochem Mol Biol 47:173-182
32. Spelsberg TC, Halberg F 1980 Circannual rhythms in steroid receptor concentration and nuclear binding in the chick oviduct. Endocrinology 107:1234-1244
33. Horwitz KB, Mockus MB, Lessey BA 1982 Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28:633-642
34. Sartorius CA, Groshong SD, Miller LA, Powell RP, Tung L, Takimoto GS, Horwitz KB 1994 New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877
35. Heichman KA, Roberts JM 1994 Rules to replicate by. Cell 79:557-562
36. Hunter T, Pines J 1994 Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79:573-582
37. King RW, Jackson PK, Kirschner MW 1994 Mitosis in transition. Cell 79:563-571
38. Nurse P 1994 Ordering S phase and M phase in the cell cycle. Cell 79:547-550
39. Sherr CJ 1994 G1 phase progression: cycling on cue. Cell 79:551-555
40. Weinberg RA 1995 The retinoblastoma protein and cell cycle control. Cell 81:323-330
41. Peter M, Herskowitz I 1994 Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184
42. Horwitz KB, Pike AW, Gonzalez-Aller C, Fennessey PV 1986 Progesterone metabolism in T47Dco human breast cancer cells. II. Intracellular metabolic pathway of progesterone and synthetic progestins. J Steroid Biochem 25:911-916
43. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
44. 1 cyclin-dependent kinases. Genes Dev 9:1149-1163
45. Serrano M, Hannon GJ, Beach D 1993 A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 366:704-707
46. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
47. Xu J-H, Hu S-X, Benedict WF 1991 Lack of nuclear RB protein staining in GO/middle G1 cells: correlation to changes in total RB protein level. Oncogene 6:1139-1146
48. Chrysogelos SA, Dickson RB 1994 EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 29:29-40
49. Dotzlaw H, Miller T, Karvelas J, Murphy LC 1990 Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res 50: 4204-4208
50. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL 1994 The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 29:41-49
51. Murphy LC, Dotzlaw H, Johnson Wong MS, Miller T, Murphy LJ 1991 Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Cancer Res 51:2051-2057
52. Murphy LC, Murphy LJ, Shiu RPC 1988 Progestin regulation of EGF receptor mRNA accumulation in T47D human breast cancer cells. Biochem Biophys Res Commun 150:192-196
53. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496
54. Sedlacek SM, Horwitz KB 1984 The role of progestins and progesterone receptors in the treatment of breast cancer. Steroids 44:467-484
55. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient vs. sustained extracellular signal-regulated kinase activation. Cell 80:179-185
56. Liu Y, Martindale JL, Gorospe M, Holbrook NJ 1996 Regulation of p21waf/cip1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56:31-35
57. Zhang H, Hannon GH, Beach D 1994 p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750-1758
58. Matsushine H, Quelle DE, Shurtleff SA, Shibuya M, Sheer CJ, Kato J-Y 1994 D-Type cyclin-dependent protein kinase activity in mammalian cells. Mol Cell Biol 14:2066-2067
59. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E 1997 New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862
60. Blenis J 1993 Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90:5889-5882
61. Galcheva-Gargova Z, Konstantinov KN, Wu IH, Klier FG, Barrett T, Davis RJ 1996 Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science 272:1797-1802
62. 185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl Acad Sci USA 89:1330-1334
63. Dikic I, Schlessinger J, Lax I 1994 PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol 4:702-708
64. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A 1994 EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4:694-701
65. Yamauchi K, Pessin JE 1994 Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol Cell Biol 14:4427-4434
66. Sarup JC, Rao KVS, Fox CF 1988 Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor. Cancer Res 48:5071-5078
67. Haslam SZ, Counterman LJ, Nummy KA 1993 Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J Cell Physiol 155:72-78
68. Krusekopf S, Chauchereau A, Milgrom E, Henderson D, Cato ACB 1991 Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol 40:239-245
69. Modiano JF, Kokai Y, Weiner DB, Pykett MJ, Nowell PC, Lyttle CR 1991 Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line. J Cell Biochem 45:196-206
70. Krishan A 1975 Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188-193
71. Estes PA, Suba EJ, Lawler-Heavner J, Wei LL, Tort DO, Horwitz KB, Edwards DP 1987 Immunologic analysis of human breast cancer progesterone receptors. I. Immunoaffinity purification of transformed receptors and monoclonal antibody production. Biochemistry 26:6250-6262
72. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685